Are ecstasy induced serotonergic alterations overestimated for the majority of users?

Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) project

(2016) Tibor M. Brunt et al.   Drug Testing and Analysis

Crystals and tablets in the Spanish ecstasy market 2000–2014: Are they the same or different in terms of purity and adulteration?

(2016) Claudio Vidal Giné et al.   FORENSIC SCIENCE INTERNATIONAL

Meta-analysis of molecular imaging of serotonin transporters in ecstasy/polydrug users

(2016) Carl. Alexander Roberts et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample

(2015) Adam Winstock et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Harms from other people's drinking: an international survey of their occurrence, impacts on feeling safe and legislation relating to their control

(2015) Mark A Bellis et al.   BMJ Open

In abstinent MDMA users the cortisol awakening response is off-set but associated with prefrontal serotonin transporter binding as in non-users

(2014) Vibe Gedsoe Frokjaer et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Effects of MDMA and Intranasal Oxytocin on Social and Emotional Processing

(2014) Matthew G Kirkpatrick et al.   NEUROPSYCHOPHARMACOLOGY

MDMA effects consistent across laboratories

(2014) Matthew G. Kirkpatrick et al.   PSYCHOPHARMACOLOGY

Use of Silk Road, the online drug marketplace, in the United Kingdom, Australia and the United States

(2013) Monica J. Barratt et al.   ADDICTION

MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational ‘Ecstasy’ users

(2013) Andrew C. Parrott   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

MDMA enhances emotional empathy and prosocial behavior

(2013) Cédric M. Hysek et al.   Social Cognitive and Affective Neuroscience

Pharmacological characterization of designer cathinonesin vitro

(2012) LD Simmler et al.   BRITISH JOURNAL OF PHARMACOLOGY

Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study

(2012) Michael C Mithoefer et al.   JOURNAL OF PSYCHOPHARMACOLOGY

A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD)

(2012) Peter Oehen et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Sustained Recreational Use of Ecstasy Is Associated with Altered Pre and Postsynaptic Markers of Serotonin Transmission in Neocortical Areas: A PET Study with [11C]DASB and [11C]MDL 100907

(2012) Nina BL Urban et al.   NEUROPSYCHOPHARMACOLOGY

The Effects of Ecstasy (MDMA) on Brain Serotonin Transporters Are Dependent on Age-of-First Exposure in Recreational Users and Animals

(2012) Anne Klomp et al.   PLoS One

Influence of different cellular environments on [3H]DASB radioligand binding

(2012) D.R. Quelch et al.   SYNAPSE

In Vivo Imaging of Cerebral Serotonin Transporter and Serotonin2A Receptor Binding in 3,4-Methylenedioxymethamphetamine (MDMA or “Ecstasy”) and Hallucinogen Users

(2011) David Erritzoe et al.   ARCHIVES OF GENERAL PSYCHIATRY

Mapping serotonergic dysfunction in MDMA (ecstasy) users using pharmacological MRI

(2011) M.L.J. Schouw et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Pharmacogenetic studies of change in cortisol on ecstasy (MDMA) consumption

(2011) Kim Wolff et al.   JOURNAL OF PSYCHOPHARMACOLOGY

A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans

(2011) Matthew G. Kirkpatrick et al.   PSYCHOPHARMACOLOGY

Is Ecstasy an “Empathogen”? Effects of ±3,4-Methylenedioxymethamphetamine on Prosocial Feelings and Identification of Emotional States in Others

(2010) Gillinder Bedi et al.   BIOLOGICAL PSYCHIATRY

Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[11C]DASB and structural brain imaging study

(2010) Stephen J. Kish et al.   BRAIN

Variability in the 3,4-methylenedioxymethamphetamine content of 'ecstasy' tablets in the UK

(2010) D. M. Wood et al.   EMERGENCY MEDICINE JOURNAL

The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study

(2010) Michael C Mithoefer et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Brain serotonin transporter binding in former users of MDMA (‘ecstasy’)

(2009) Sudhakar Selvaraj et al.   BRITISH JOURNAL OF PSYCHIATRY

Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users

(2008) M. M. L. de Win et al.   BRAIN

Dance Clubbing on MDMA and during Abstinence from Ecstasy/MDMA: Prospective Neuroendocrine and Psychobiological Changes

(2008) A.C. Parrott et al.   NEUROPSYCHOBIOLOGY